CNC · Centene Corp
$67.47
+1.43 (+2.17%)
At close · Aug 14
Market Cap
$33.33B
Shares
494.00M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Sarah London | Chief Executive Officer | $19,506,298 |
| Andrew Asher | Chief Financial Officer | $16,072,880 |
| Christopher A. Koster | Secretary and General Counsel | $6,508,793 |
| Susan R. Smith | Chief Operating Officer | $4,887,083 |
| Tanya McNally | Chief People Officer | $3,172,356 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Sarah London | Chief Executive Officer | $20,602,148 |
| Andrew Asher | Chief Financial Officer | $11,182,412 |
| Kenneth Fasola | Former President/Strategic Advisor | $9,023,201 |
| Christopher A. Koster | Secretary and General Counsel | $5,063,538 |
| Susan R. Smith | Chief Operating Officer | $3,522,452 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Sarah London | Chief Executive Officer | $18,556,966 |
| Kenneth Fasola | Former President/Strategic Advisor | $10,616,034 |
| Andrew Asher | Chief Financial Officer | $9,912,064 |
| James Murray | Executive Vice President | $6,286,086 |
| David P. Thomas | Chief Executive Officer of Markets and Medicaid | $6,198,108 |
| Christopher A. Koster | Secretary and General Counsel | $4,844,337 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Sarah London | Chief Executive Officer | $13,246,447 |
| Kenneth Fasola | Former President/Strategic Advisor | $9,982,686 |
| Andrew Asher | Chief Financial Officer | $9,739,210 |
| Michael Neidorff | Former Chairman and Chief Executive Officer | $7,599,513 |
| Brent Layton | Senior Advisor to the Chief Executive Officer and former President and Chief Operating Officer | $6,910,926 |
| James Murray | Executive Vice President | $6,270,418 |
| David P. Thomas | Chief Executive Officer of Markets and Medicaid | $4,633,756 |
| Christopher A. Koster | Secretary and General Counsel | $2,422,528 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Michael Neidorff | Former Chairman and Chief Executive Officer | $20,637,990 |
| Sarah London | Chief Executive Officer | $15,227,522 |
| Brent Layton | Senior Advisor to the Chief Executive Officer and former President and Chief Operating Officer | $14,105,744 |
| Andrew Asher | Chief Financial Officer | $8,199,038 |
| Christopher A. Koster | Secretary and General Counsel | $5,985,832 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Michael Neidorff | Former Chairman and Chief Executive Officer | $24,956,777 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Michael Neidorff | Chairman, President and Chief Executive Officer | $26,438,425 |
| Jeffrey A. Schwaneke | Executive Vice President, Chief Financial Officer and Treasurer | $9,434,284 |
| Brandy L. Burkhalter | Executive Vice President, Chief Operating Officer | $8,637,416 |
| Jesse N. Hunter | Executive Vice President and Chief Strategy Officer | $6,118,969 |
| Mark J. Brooks | Executive Vice President, Chief Information Officer | $4,410,005 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Michael Neidorff | Chairman, President and Chief Executive Officer | $26,122,414 |
| Jeffrey A. Schwaneke | Executive Vice President, Chief Financial Officer and Treasurer | $9,960,954 |
| Brandy L. Burkhalter | Executive Vice President, Chief Operating Officer | $7,573,238 |
| Jesse N. Hunter | Executive Vice President and Chief Strategy Officer | $6,164,144 |
| Mark J. Brooks | Executive Vice President, Chief Information Officer | $4,035,672 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Michael Neidorff | Chairman, President and Chief Executive Officer | $25,259,468 |
| Jeffrey A. Schwaneke | Executive Vice President, Chief Financial Officer and Treasurer | $5,546,562 |
| Jesse N. Hunter | Executive Vice President and Chief Strategy Officer | $4,962,844 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Paul Diaz | Director | Appointed | 2026-07-28 |
| Kenneth Burdick | Director | Resigned | 2026-07-28 |
| Lauren Tyler | Board of Directors | Appointed | 2026-06-22 |
| Theodore Pienkos | Corporate Controller and Chief Accounting Officer | Appointed | 2026-05-15 |
| Christopher Koster | General Counsel | Appointed | 2026-05-15 |
| Susan Smith | Chief Operations Officer | Appointed | 2026-05-15 |
| Michael Carson | Group President, Medicare and Specialty | Appointed | 2026-05-15 |
| Daniel Finke | Group President, Medicaid and Marketplace | Appointed | 2026-05-15 |
| Drew Asher | Chief Financial Officer | Appointed | 2026-05-15 |
| Sarah London | Chief Executive Officer | Appointed | 2026-05-15 |
| Kate Casso | Senior Vice President, Finance Operations and Innovation | Appointed | 2026-03-24 |
| Theodore Pienkos | Corporate Controller and Chief Accounting Officer | Appointed | 2026-03-24 |
| Thomas R. Greco | Director | Resigned | 2025-08-15 |
| Wayne S. DeVeydt | Director | Resigned | 2025-08-04 |
| Kenneth Tanji | Board of Directors | Appointed | 2025-02-24 |
| Kenneth J. Fasola | President | Retired | 2024-11-12 |
| Thomas Greco | Director | Appointed | 2024-08-15 |
| James E. Murray | from the Company | Retired | 2024-03-29 |
| Susan Smith | Chief Operating Officer | Appointed | 2023-11-15 |
| Brian LeClaire, MBA, PhD | Chief Information Officer | Appointed | 2022-12-14 |
| James Murray | Executive Vice President, Chief Operating Officer of the Company | Appointed | 2022-12-14 |
| Alice H. Chen, MD, MPH | Chief Health Officer | Appointed | 2022-12-14 |
| Kenneth Fasola | President of the Company | Appointed | 2022-12-14 |
| Monte Ford | Board of Directors | Appointed | 2022-11-16 |
Key facts
CIK
1071739
CUSIP
15135B101
13F (30d)
911 filings
879 filers
Visit website
Investor relations